Related Experiment Videos
Long-term outcomes in rheumatoid arthritis
1Vanderbilt University Medical Center, Department of Medicine, Nashville, TN, USA.
British Journal of Rheumatology
|November 1, 1995
Summary
Long-term rheumatoid arthritis (RA) can lead to severe disability and mortality. Sustained inflammation, not initial disease severity, predicts these poor outcomes, suggesting early aggressive treatment is crucial.
Area of Science:
- Rheumatology
- Immunology
- Clinical Medicine
Background:
- Established rheumatoid arthritis (RA) frequently results in long-term radiographic progression, functional decline, work disability, and premature mortality.
- Observational studies show traditional RA therapies are often discontinued within two years.
- Sustained inflammatory activity is a stronger predictor of severe long-term outcomes than baseline disease measures.
Purpose of the Study:
- To evaluate the predictors of severe long-term outcomes in rheumatoid arthritis.
- To emphasize the importance of sustained inflammatory control in RA management.
Main Methods:
- Analysis of long-term clinical observational studies on rheumatoid arthritis patients.
- Comparison of baseline disease activity measures versus sustained inflammatory activity in predicting outcomes.
Main Results:
- Sustained inflammatory activity more effectively predicts severe long-term outcomes in RA than single-point baseline assessments.
- Traditional RA therapies have limited long-term adherence.
Conclusions:
- Aggressively controlling inflammatory activity early in rheumatoid arthritis is a reasonable and potentially effective treatment strategy.
- Preventing irreversible joint damage through sustained inflammation suppression is key to improving long-term RA patient prognosis.